Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Sachs

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
Molecular Psychiatry|October 20, 2020
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosisThomas A Pollak, Matthew J Kempton, Conrad Iyegbe, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Schizophrenia (Heidelberg, Germany)|October 7, 2024
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCANMargot I E Slot, Maria F Urquijo Castro, Inge Winter-van Rossum, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
JAMA Psychiatry|August 29, 2020
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in AdolescenceDavid Mongan, Melanie Föcking, Colm Healy, et al.
Schizophrenia Bulletin|August 20, 2019
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical PracticeStefania Tognin, Hendrika H van Hell, Kate Merritt, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI studyStephanie Menghini-Müller, Erich Studerus, Sarah Ittig, et al.
Schizophrenia Research. Cognition|April 4, 2024
PsyCog: A computerised mini battery for assessing cognition in psychosisGeorge Gifford, Alexis E Cullen, Sandra Vieira, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Schizophrenia Bulletin|July 25, 2024
Do Cognitive Subtypes Exist in People at Clinical High Risk for Psychosis? Results From the EU-GEI StudyGeorge Gifford, Alessia Avila, Matthew J Kempton, et al.
Molecular Psychiatry|October 20, 2020
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosisThomas A Pollak, Matthew J Kempton, Conrad Iyegbe, et al.
Schizophrenia Bulletin|August 21, 2021
Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for PsychosisFrederike Schirmbeck, Nadine C van der Burg, Matthijs Blankers, et al.
Schizophrenia (Heidelberg, Germany)|October 7, 2024
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCANMargot I E Slot, Maria F Urquijo Castro, Inge Winter-van Rossum, et al.
JAMA Psychiatry|November 14, 2019
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for PsychosisGemma Modinos, Matthew J Kempton, Stefania Tognin, et al.
JAMA Psychiatry|August 29, 2020
Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in AdolescenceDavid Mongan, Melanie Föcking, Colm Healy, et al.
Schizophrenia Bulletin|August 20, 2019
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies-PSYSCAN: Translating Neuroimaging Findings From Research into Clinical PracticeStefania Tognin, Hendrika H van Hell, Kate Merritt, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Gender differences of patients at-risk for psychosis regarding symptomatology, drug use, comorbidity and functioning - Results from the EU-GEI studyStephanie Menghini-Müller, Erich Studerus, Sarah Ittig, et al.
Schizophrenia Research. Cognition|April 4, 2024
PsyCog: A computerised mini battery for assessing cognition in psychosisGeorge Gifford, Alexis E Cullen, Sandra Vieira, et al.
Pageof 6